Bio Digital Patent

Harbor Healthcare Advises a California Long-Term Care Pharmacy On Its Sale & Strategic Partnership

The long-term relationships and immensity of the California market also made it a strategic advancement for the acquirer. Facilities and patients...

 January 04, 2023 | News

Vistagen Advances Intellectual Property Program to Expand Patent Protection for PH94B to Include Treatment of Adjustment Disorder

-Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxi...

 January 03, 2023 | News

ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome

 ExoCoBio Inc., one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims tha...

 May 09, 2022 | News

GenNext Technologies announces second US protein footprinting patent

The United States Patent and Trademark Office (USPTO) has issued Patent US 11,181,529 B2: "Radical Dosimetry for the Analysis of Biopharmaceuticals and Bio...

 December 10, 2021 | News

How Pfizer boosted security levels across its global manufacturing facilities

Secondly, OT networks are particularly vulnerable because they operate with many proprietary, and often legacy, devices that can be difficult to identify a...

 August 18, 2021 | Opinion | By Guilad Regev, SVP Customer Care, Claroty

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two compa...

 July 09, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

 July 02, 2021 | News

Japan's PMDA enters 8th consecutive year of using Certara’s biosimulation software

Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of&...

 June 25, 2021 | News

Zuellig Pharma to advance Cyber-intelligence Capabilities

Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture   CYFIRMA, a threat discovery and cyb...

 June 25, 2021 | News

Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan

Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...

 June 23, 2021 | News

EYEMATE-SC Biosensor for Remote Glaucoma Care is CE Marked

The patented EYEMATE system is the world’s only clinically-validated product used for comprehensive remote glaucoma monitoring. US FDA Breakthrough D...

 June 21, 2021 | News

Orexo continues to strengthen ZUBSOLV´s patent portfolio

The new patents, US Patent Nos. 11,020,387 and 11,020,388, expire in September 2032. Orexo will now have nine patents listed in the Orange Book relati...

 June 02, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in